Viewing StudyNCT00481091



Ignite Creation Date: 2024-05-05 @ 5:35 PM
Last Modification Date: 2024-10-26 @ 9:33 AM
Study NCT ID: NCT00481091
Status: COMPLETED
Last Update Posted: 2023-06-13
First Post: 2007-05-30

Brief Title: A Study of ABT-263 in Participants With Relapsed or Refractory Chronic Lymphocytic Leukemia
Sponsor: AbbVie
Organization: AbbVie

Conditions & Keywords Data

Conditions:
Name
Chronic Lymphocytic Leukemia
Keywords:
Name View
Chronic Lymphocytic Leukemia CLL View
Navitoclax View
ABT-263 View
Cancer View